If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
other |
not provided |
total |
196
|
298
|
298
|
79
|
102
|
23
|
35
|
1004
|
Gene and significance breakdown #
Total genes and gene combinations: 61
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
other |
not provided |
total |
ROBO2
|
2
|
0 |
73
|
34
|
77
|
0 |
0 |
175
|
TP53
|
11
|
119
|
0 |
0 |
0 |
0 |
0 |
126
|
RB1
|
11
|
4
|
102
|
1
|
0 |
0 |
0 |
118
|
TNXB
|
4
|
6
|
69
|
13
|
15
|
0 |
2
|
108
|
TSC1
|
7
|
0 |
2
|
0 |
0 |
0 |
33
|
42
|
FGFR3
|
15
|
7
|
12
|
5
|
1
|
0 |
0 |
37
|
PIK3CA
|
1
|
32
|
0 |
0 |
0 |
0 |
0 |
33
|
HRAS, LRRC56
|
7
|
13
|
7
|
4
|
0 |
0 |
0 |
26
|
MRE11
|
0 |
0 |
0 |
0 |
0 |
23
|
0 |
23
|
CTNNB1, LOC126806658
|
2
|
21
|
0 |
0 |
0 |
0 |
0 |
22
|
ARID1A
|
20
|
0 |
1
|
0 |
0 |
0 |
0 |
21
|
BRCA2
|
20
|
0 |
0 |
0 |
0 |
0 |
0 |
20
|
ABCG8
|
1
|
0 |
12
|
2
|
1
|
0 |
0 |
16
|
KRAS
|
5
|
1
|
4
|
6
|
0 |
0 |
0 |
16
|
LOC106780803, TNXB
|
0 |
0 |
5
|
7
|
4
|
0 |
0 |
16
|
ERBB2
|
5
|
10
|
0 |
0 |
0 |
0 |
0 |
15
|
ATM
|
12
|
0 |
0 |
0 |
0 |
0 |
0 |
12
|
BRAF
|
0 |
11
|
0 |
0 |
0 |
0 |
0 |
11
|
NF1
|
11
|
0 |
0 |
0 |
0 |
0 |
0 |
11
|
SOX17
|
2
|
1
|
2
|
6
|
1
|
0 |
0 |
11
|
ATM, C11orf65
|
10
|
0 |
0 |
0 |
0 |
0 |
0 |
10
|
FBXW7
|
0 |
10
|
0 |
0 |
0 |
0 |
0 |
10
|
KDM6A
|
9
|
0 |
0 |
0 |
0 |
0 |
0 |
9
|
BRCA1
|
8
|
0 |
0 |
0 |
0 |
0 |
0 |
8
|
ERBB3
|
4
|
5
|
0 |
0 |
0 |
0 |
0 |
8
|
LOC126806727, ROBO2
|
0 |
0 |
5
|
1
|
2
|
0 |
0 |
8
|
NFE2L2
|
0 |
8
|
0 |
0 |
0 |
0 |
0 |
8
|
NRAS
|
0 |
8
|
0 |
0 |
0 |
0 |
0 |
8
|
CDKN2A
|
2
|
5
|
0 |
0 |
0 |
0 |
0 |
7
|
EGFR
|
6
|
0 |
0 |
0 |
0 |
0 |
0 |
6
|
IDH1
|
0 |
5
|
0 |
0 |
0 |
0 |
0 |
5
|
PTEN
|
3
|
1
|
1
|
0 |
0 |
0 |
0 |
5
|
CREBBP
|
0 |
4
|
0 |
0 |
0 |
0 |
0 |
4
|
ERCC2
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
4
|
MAP2K1
|
0 |
3
|
0 |
0 |
0 |
0 |
0 |
3
|
SF3B1
|
0 |
3
|
0 |
0 |
0 |
0 |
0 |
3
|
intergenic
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
2
|
BRCA1, LOC126862571
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
CDKN1A
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
2
|
CNOT9
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
CYP21A2, TNXB
|
0 |
0 |
1
|
0 |
1
|
0 |
0 |
2
|
EFEMP1
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
EP300
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
FGFR1
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
HARS1
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
LOC110806263, TERT
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
MTOR
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
RHEB
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
RXRA
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
U2AF1
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
ABCG5, ABCG8
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
AFAP1L2, VWA2
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
AKT1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
C12orf57
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
CTNNA3
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
EBF3
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
KAT6B
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
LOC126859654, TNXB
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
MAPK1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
MED13L
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
NIPBL
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
other |
not provided |
total |
Database of Curated Mutations (DoCM)
|
0 |
280
|
0 |
0 |
0 |
0 |
0 |
280
|
Illumina Laboratory Services, Illumina
|
0 |
0 |
64
|
21
|
76
|
0 |
0 |
161
|
Laboratory of Urology, Hospital Clinic de Barcelona
|
150
|
0 |
6
|
0 |
0 |
0 |
0 |
156
|
Fulgent Genetics, Fulgent Genetics
|
19
|
0 |
63
|
56
|
15
|
0 |
0 |
153
|
Baylor Genetics
|
1
|
2
|
99
|
0 |
0 |
0 |
0 |
102
|
Revvity Omics, Revvity
|
2
|
7
|
30
|
0 |
0 |
0 |
0 |
39
|
Tuberous sclerosis database (TSC1)
|
0 |
0 |
0 |
0 |
0 |
0 |
33
|
33
|
Gray Institute for Radiation Oncology & Biology, University of Oxford
|
0 |
0 |
0 |
0 |
0 |
23
|
0 |
23
|
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
|
2
|
0 |
19
|
1
|
0 |
0 |
0 |
22
|
OMIM
|
12
|
0 |
1
|
0 |
0 |
0 |
0 |
13
|
Juno Genomics, Hangzhou Juno Genomics, Inc
|
5
|
2
|
2
|
0 |
0 |
0 |
0 |
9
|
Genome-Nilou Lab
|
0 |
0 |
0 |
0 |
9
|
0 |
0 |
9
|
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
|
1
|
0 |
5
|
0 |
0 |
0 |
0 |
6
|
Mendelics
|
1
|
2
|
0 |
1
|
1
|
0 |
0 |
5
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
|
1
|
2
|
1
|
0 |
0 |
0 |
0 |
4
|
Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center
|
0 |
0 |
4
|
0 |
0 |
0 |
0 |
4
|
Johns Hopkins Genomics, Johns Hopkins University
|
0 |
0 |
2
|
1
|
0 |
0 |
0 |
3
|
Genome Diagnostics Laboratory, University Medical Center Utrecht
|
0 |
0 |
0 |
0 |
2
|
0 |
0 |
2
|
Talkowski Laboratory, Center for Human Genetic Research, Massachusetts General Hospital
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
2
|
GenomeConnect, ClinGen
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
|
0 |
0 |
0 |
0 |
2
|
0 |
0 |
2
|
Women's and Children's Health, University of Otago
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Fondazione Stella Maris
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
New York Genome Center
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
Genomic Research Center, Shahid Beheshti University of Medical Sciences
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Bioinformatics dept., Datar Cancer Genetics Limited, India
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
NIHR Bioresource Rare Diseases, University of Cambridge
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Institute of Human Genetics, University of Leipzig Medical Center
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Yale Center for Mendelian Genomics, Yale University
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Human Genetic Laboratory, University of Liege
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Genomic Center, National Cancer Institute
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Dr. med. U. Finckh, Human Genetics, Eurofins MVZ
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
MVZ Medizinische Genetik Mainz
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Immunogenetics and Transplant Biology Service, University Hospital "Città della Salute e della Scienza di Torino"
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.